--Edwards Lifesciences Guides For Q3 EPS of $0.67-$0.71 on Sales of $1.56-$1.64 Billion, vs CIQ Analyst Consensus of $0.69 Non-GAAP, $0.67 GAAP, on Revenue of $1.62 Billion
04:17 PM EDT, 07/24/2024 (MT Newswires) --
Price: 80.60, Change: -6.35, Percent Change: -7.30